From what I see, Quantum Computing Inc. (QUBT) stands out as an integrated photonics company developing quantum machines and quantum-inspired solutions for both commercial and government markets. The core business centers on thin-film lithium niobate chips for optical devices, such as electro-optical modulators and micro-ring resonators, along with products like the entropy quantum computer (EQC) for optimization problems, Emucore and Neurawave reservoir computing systems, LiDAR for harsh environments, and quantum networks. In the still-nascent quantum computing industry, QUBT sets itself apart through photonic technologies that allow room-temperature operation, positioning it against competitors like IONQ. Recent acquisitions have bolstered manufacturing capabilities, which has supported revenue growth and helps explain the stock's resilience despite volatility linked to early-stage tech exposure.
In the last 30 days, QUBT stock has climbed +25%, rising from around $8.11 in mid-April to a recent close of $10.18. This advance has been volatile and trend-driven, featuring sharp gains following the Q1 earnings release on May 11, when shares surged over 6% intraday on high volume exceeding 30 million shares.
Looking at the past quarter, the stock is up +14%, having recovered from February levels near $8.54. The performance included a dip to $6.18 lows in late March before rebounding—a pattern typical of range-bound trading followed by upward momentum in this speculative sector.
The main catalyst in the last 30 days was the Q1 2026 earnings released around May 11, which reported $3.7 million in revenue—surpassing estimates of $3.13 million—thanks to the Luminar Semiconductor acquisition closed in February. Even with a net loss and EPS of -$0.02 (better than the -$0.05 expected), the revenue growth highlighted successful integration. Shares spiked 14% post-earnings, as covered in Barron's, reversing the stock's prior underperformance. Analyst buy ratings, including Rosenblatt's $22 target, along with others, helped sustain the momentum, while hype in the quantum sector around photonics platforms like NeuraWave added to the positive sentiment. High short interest near 30% also created squeeze potential during the rally. I also checked this using Tickeron’s AI Screener to gauge how QUBT stacks up against peers.
The quarter's +strong performance came from ongoing narratives around strategic expansion, particularly the $110 million Luminar Semiconductor deal, which enhanced photonics foundry capabilities and Fab 1 operations. Earlier dips mirrored broader market caution toward quantum stocks amid macroeconomic pressures like interest rates, but the recovery linked to partnerships with NASA, Johns Hopkins, and POET Technologies, plus product milestones such as the NeuraWave launch. Institutional interest has picked up, supported by cash reserves over $1.5 billion following recent raises, which offset dilution concerns. Broader sector trends in AI-quantum convergence and defense applications overshadowed volatility from short-seller reports, with revenue visibility post-acquisition driving the overall uptrend.
In my own trading and research, I often turn to Tickeron’s Trending AI Robots page, which highlights the platform's top-performing AI trading bots from hundreds available. These bots analyze and trade thousands of tickers across various markets using strategies like trend-following, mean reversion, or momentum over horizons from intraday to long-term. Performance metrics such as win rate, profit factor, and Sharpe ratio provide clear transparency. They're selected based on recent profitability, relevance to market trends, and statistical edge, making them useful for automating trades in volatile areas like quantum tech. I find it valuable to explore this page, match bots to my risk profile, and backtest them on stocks like QUBT.
One thing that stands out for investors is monitoring Q2 earnings for continued revenue from acquisitions and Fab 1 foundry services. Progress on NeuraWave deployment and potential new partnerships in defense or AI will likely sway sentiment. Keep an eye on industry trends in photonic quantum advancements relative to rivals, as well as macroeconomic factors like interest rates affecting tech valuations. Regulatory shifts in quantum tech funding and changes in institutional ownership deserve attention too. On the risk side, watch for execution delays in scaling production, dilution from capital raises, and the sector's hype cycles. I'm watching this closely as these elements could determine the next move for QUBT.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
The RSI Oscillator for QUBT moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In 24 of the 25 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Moving Average Convergence Divergence (MACD) for QUBT just turned positive on October 27, 2026. Looking at past instances where QUBT's MACD turned positive, the stock continued to rise in 44 of 45 cases over the following month. The odds of a continued upward trend are 90%.
Following a +7.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where QUBT advanced for three days, in 195 of 228 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
QUBT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 53 cases where QUBT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 89%.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QUBT as a result. In 71 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
QUBT moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for QUBT crossed bearishly below the 50-day moving average on October 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QUBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for QUBT entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.900) is normal, around the industry mean (-6.624). QUBT's P/E Ratio (-158.250) is considerably lower than the industry average of (-3.277). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (23.994). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (169.492) is also within normal values, averaging (51.774).
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. QUBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 98 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QUBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerProcessingHardware